Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FBT vs IBBQ
Shared holdings
23
FBT covered by IBBQ
31.64%
IBBQ covered by FBT
31.64%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 32 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FBT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 5.26% | |
| UNITED THERAPEUTICS CORP DEL | 4.36% | |
| ALKERMES PLC | 4.23% | |
| GILEAD SCIENCES INC | 4.09% | |
| AXSOME THERAPEUTICS INC | 3.88% | |
| AMGEN INC | 3.83% | |
| CORCEPT THERAPEUTICS INC | 3.82% | |
| KRYSTAL BIOTECH INC | 3.51% | |
| BIOGEN INC | 3.47% | |
| EXELIXIS INC | 3.46% | |
| NEUROCRINE BIOSCIENCES INC | 3.44% | |
| REGENERON PHARMACEUTICALS INC | 3.44% | |
| VERTEX PHARMACEUTICALS INC | 3.42% | |
| BIOMARIN PHARMACEUTICAL INC | 3.40% | |
| ARGENX SE SPONSORED ADR | 3.29% | |
| SAREPTA THERAPEUTICS INC | 3.24% | |
| HALOZYME THERAPEUTICS INC | 3.17% | |
| BIONTECH SE ADR | 3.16% | |
| INCYTE CORP | 3.13% | |
| BEONE MEDICINES LTD ADR | 3.12% | |
| ILLUMINA INC | 3.10% | |
| NATERA INC | 3.03% | |
| ACADIA PHARMACEUTICALS INC | 2.95% | |
| ALNYLAM PHARMACEUTICALS INC | 2.95% | |
| BIO-TECHNE CORP | 2.82% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 2.78% | |
| VERACYTE INC | 2.72% | |
| REPLIGEN CORP | 2.51% | |
| BRUKER CORP | 2.35% | |
| NEOGENOMICS INC | 2.00% | |
| DREY-GVT CSH-I | 0.06% | |
| DAIWA CAPITAL MARKETS AMERICA INC | 0.01% |
IBBQ (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 11.93% | |
| GILEAD SCIENCES INC | 8.02% | |
| VERTEX PHARMACEUTICALS INC | 7.77% | |
| AMGEN INC | 7.62% | |
| REGENERON PHARMACEUTICALS INC | 5.03% | |
| Invesco Private Government Fund | 4.63% | |
| ALNYLAM PHARMACEUTICALS INC | 2.74% | |
| INSMED INC | 1.99% | |
| BIOGEN INC | 1.75% | |
| ARGENX SE SPONSORED ADR | 1.39% | |
| UNITED THERAPEUTICS CORP DEL | 1.35% | |
| MODERNA INC | 1.31% | |
| ILLUMINA INC | 1.28% | |
| ROIVANT SCIENCES | 1.26% | |
| INCYTE CORP | 1.24% | |
| ROYALTY PHARMA-A | 1.23% | |
| REVOLUTION MEDICINES INC | 1.23% | |
| VIATRIS INC | 1.07% | |
| Ascendis Pharma A/S | 0.89% | |
| NEUROCRINE BIOSCIENCES INC | 0.82% | |
| IONIS PHARMACEUTICALS INC | 0.82% | |
| SANOFI SPON ADR | 0.80% | |
| BRIDGEBIO PHARMA INC | 0.80% | |
| MEDPACE HOLDINGS INC | 0.79% | |
| SUMMIT THERAPEUTICS INC | 0.77% | |
| GUARDANT HEALTH INC | 0.76% | |
| BIOMARIN PHARMACEUTICAL INC | 0.74% | |
| EXELIXIS INC | 0.74% | |
| JAZZ PHARMACEUTI | 0.72% | |
| BIONTECH SE ADR | 0.70% | |
| BEONE MEDICINES LTD ADR | 0.62% | |
| MADRIGAL PHARMACEUTICALS INC | 0.61% | |
| IMMUNITYBIO INC | 0.60% | |
| TEMPUS AI INC-A | 0.58% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.54% | |
| PRAXIS PRECISION MEDICINES INC | 0.53% | |
| AXSOME THERAPEUTICS INC | 0.51% | |
| HALOZYME THERAPEUTICS INC | 0.51% | |
| VAXCYTE INC | 0.51% | |
| KRYSTAL BIOTECH INC | 0.50% | |
| CYTOKINETICS INC | 0.47% | |
| NUVALENT INC-A | 0.46% | |
| Abivax SA SPONSORED ADS | 0.45% | |
| ARCELLX INC | 0.41% | |
| KYMERA THERAPEUTICS INC | 0.41% | |
| RHYTHM PHARMACEUTICALS INC | 0.39% | |
| COGENT BIOSCIENCES INC | 0.37% | |
| PROTAGONIST THERAPEUTICS INC | 0.36% | |
| CRISPR Therapeutics A.G. Series A | 0.36% | |
| CARIS LIFE SCIENCES INC | 0.35% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.